Mortality and Morbidity in Transsexual Patients With Cross-Gender Hormone Treatment

The number of deaths & morbidity cases in 425 transsexual patients treated with cross-gender hormones were evaluated retrospectively & compared with the expected number in a similar reference group of the population. The number of deaths in male-to-female transsexuals was five times the number expected, due to increased numbers of suicide & deaths of unknown cause. (35 refs)